A prospective study of prophylactic ATG versus cyclosporine in regrafted and highly sensitized renal allograft recipients.
Pearson
R C
RC
Renal Transplant Unit, St. Mary's Hospital, Manchester, United Kingdom.
Johnson
R W
RW
Bakran
A
A
Dyer
P
P
Martin
S
S
O'Donoghue
D
D
Scott
P D
PD
D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D003524:Cyclosporins / Q000627:therapeutic use*; D005260:Female; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012086:Reoperation; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D003524:Cyclosporins